Cargando…
MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma
NEK2 is a member of the NIMA-related family of serine/threonine centrosomal kinases. We analyzed the relationship between differential expression of NEK2 and hepatocellular carcinoma (HCC) patient outcomes after liver transplants. We also studied the microRNAs that affect NEK2 expression. Analysis o...
Autores principales: | Fu, Shun-Jun, Chen, Jian, Ji, Fei, Ju, Wei-Qiang, Zhao, Qiang, Chen, Mao-Gen, Guo, Zhi-Yong, Wu, Lin-Wei, Ma, Yi, Wang, Dong-Ping, Zhu, Xiao-Feng, He, Xiao-Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581084/ https://www.ncbi.nlm.nih.gov/pubmed/28881785 http://dx.doi.org/10.18632/oncotarget.17635 |
Ejemplares similares
-
Exosome-Derived miR-486-5p Regulates Cell Cycle, Proliferation and Metastasis in Lung Adenocarcinoma via Targeting NEK2
por: Hu, Huihui, et al.
Publicado: (2020) -
Retraction: Exosome-Derived miR-486-5p Regulates Cell Cycle, Proliferation and Metastasis in Lung Adenocarcinoma via Targeting NEK2
Publicado: (2021) -
Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer
por: Shao, Yang, et al.
Publicado: (2016) -
Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016) -
miR-486 as an unfavorable prognostic biomarker for patients with non-small cell lung cancer
por: Gao, Zhao-Jia, et al.
Publicado: (2020)